JP2024539212A5 - - Google Patents
Info
- Publication number
- JP2024539212A5 JP2024539212A5 JP2024523839A JP2024523839A JP2024539212A5 JP 2024539212 A5 JP2024539212 A5 JP 2024539212A5 JP 2024523839 A JP2024523839 A JP 2024523839A JP 2024523839 A JP2024523839 A JP 2024523839A JP 2024539212 A5 JP2024539212 A5 JP 2024539212A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- type
- diffraction pattern
- ray powder
- powder diffraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025175882A JP2026027273A (ja) | 2021-10-20 | 2025-10-17 | キナゾリン誘導体の結晶形態、調製、組成物およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021125016 | 2021-10-20 | ||
| CNPCT/CN2021/125016 | 2021-10-20 | ||
| PCT/CN2022/126169 WO2023066296A1 (en) | 2021-10-20 | 2022-10-19 | Crystalline forms of quinazoline derivatives, preparation, composition and use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025175882A Division JP2026027273A (ja) | 2021-10-20 | 2025-10-17 | キナゾリン誘導体の結晶形態、調製、組成物およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539212A JP2024539212A (ja) | 2024-10-28 |
| JP2024539212A5 true JP2024539212A5 (https=) | 2025-10-27 |
Family
ID=86057927
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523839A Pending JP2024539212A (ja) | 2021-10-20 | 2022-10-19 | キナゾリン誘導体の結晶形態、調製、組成物およびその使用 |
| JP2025175882A Pending JP2026027273A (ja) | 2021-10-20 | 2025-10-17 | キナゾリン誘導体の結晶形態、調製、組成物およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025175882A Pending JP2026027273A (ja) | 2021-10-20 | 2025-10-17 | キナゾリン誘導体の結晶形態、調製、組成物およびその使用 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20240417403A1 (https=) |
| EP (2) | EP4399207B1 (https=) |
| JP (2) | JP2024539212A (https=) |
| KR (1) | KR20240090181A (https=) |
| CN (4) | CN119317625A (https=) |
| AU (1) | AU2022371540A1 (https=) |
| CA (1) | CA3232101A1 (https=) |
| CL (1) | CL2024001231A1 (https=) |
| CO (1) | CO2024004745A2 (https=) |
| CR (1) | CR20240163A (https=) |
| DK (1) | DK4399207T3 (https=) |
| ES (1) | ES3059167T3 (https=) |
| FI (1) | FI4399207T3 (https=) |
| HR (1) | HRP20260049T1 (https=) |
| IL (1) | IL312004A (https=) |
| LT (1) | LT4399207T (https=) |
| MA (1) | MA66471B1 (https=) |
| MX (1) | MX2024004738A (https=) |
| PE (1) | PE20242106A1 (https=) |
| PL (1) | PL4399207T3 (https=) |
| PT (1) | PT4399207T (https=) |
| RS (1) | RS67641B1 (https=) |
| SI (1) | SI4399207T1 (https=) |
| SM (1) | SMT202600023T1 (https=) |
| WO (1) | WO2023066296A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202309022A (zh) | 2021-04-13 | 2023-03-01 | 美商努法倫特公司 | 用於治療具egfr突變之癌症之胺基取代雜環 |
| WO2025195333A1 (en) | 2024-03-19 | 2025-09-25 | F. Hoffmann-La Roche Ag | Pharmaceutical formulation of erbb2 inhibitors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| DE69720965T2 (de) | 1996-02-13 | 2004-02-05 | Astrazeneca Ab | Chinazolinderivate und deren verwendung als vegf hemmer |
| NZ331191A (en) | 1996-03-05 | 2000-03-27 | Zeneca Ltd | 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| US7235537B2 (en) | 2002-03-13 | 2007-06-26 | Array Biopharma, Inc. | N3 alkylated benzimidazole derivatives as MEK inhibitors |
| ATE446294T1 (de) * | 2005-11-15 | 2009-11-15 | Array Biopharma Inc | N4-phenyl-chinazolin-4-aminderivate und verwandte verbindungen als inhibitoren der erbb-typ-i- rezeptortyrosinkinase zur behandlung hyperproliferativer krankheiten |
| WO2017148391A1 (zh) * | 2016-03-01 | 2017-09-08 | 上海医药集团股份有限公司 | 一种含氮杂环化合物、制备方法、中间体、组合物和应用 |
| EP3516071B1 (en) * | 2016-09-22 | 2021-02-17 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of lung cancer |
| TWI858848B (zh) * | 2018-05-08 | 2024-10-11 | 大陸商迪哲（江蘇）醫藥股份有限公司 | ＥｒｂＢ受體抑制劑 |
| EP4523755A3 (en) * | 2018-09-18 | 2025-06-11 | F. Hoffmann-La Roche AG | Quinazoline derivatives as antitumor agents |
-
2022
- 2022-10-19 IL IL312004A patent/IL312004A/en unknown
- 2022-10-19 PL PL22882901.6T patent/PL4399207T3/pl unknown
- 2022-10-19 DK DK22882901.6T patent/DK4399207T3/da active
- 2022-10-19 CN CN202280070755.1A patent/CN119317625A/zh active Pending
- 2022-10-19 SM SM20260023T patent/SMT202600023T1/it unknown
- 2022-10-19 SI SI202230234T patent/SI4399207T1/sl unknown
- 2022-10-19 ES ES22882901T patent/ES3059167T3/es active Active
- 2022-10-19 LT LTEPPCT/CN2022/126169T patent/LT4399207T/lt unknown
- 2022-10-19 MA MA66471A patent/MA66471B1/fr unknown
- 2022-10-19 EP EP22882901.6A patent/EP4399207B1/en active Active
- 2022-10-19 MX MX2024004738A patent/MX2024004738A/es unknown
- 2022-10-19 HR HRP20260049TT patent/HRP20260049T1/hr unknown
- 2022-10-19 US US18/702,989 patent/US20240417403A1/en active Pending
- 2022-10-19 CN CN202510509201.2A patent/CN120309620A/zh active Pending
- 2022-10-19 PE PE2024000895A patent/PE20242106A1/es unknown
- 2022-10-19 JP JP2024523839A patent/JP2024539212A/ja active Pending
- 2022-10-19 AU AU2022371540A patent/AU2022371540A1/en active Pending
- 2022-10-19 KR KR1020247012414A patent/KR20240090181A/ko active Pending
- 2022-10-19 RS RS20260048A patent/RS67641B1/sr unknown
- 2022-10-19 CN CN202510509243.6A patent/CN120309621A/zh active Pending
- 2022-10-19 CR CR20240163A patent/CR20240163A/es unknown
- 2022-10-19 CN CN202510508208.2A patent/CN120623183A/zh active Pending
- 2022-10-19 PT PT228829016T patent/PT4399207T/pt unknown
- 2022-10-19 CA CA3232101A patent/CA3232101A1/en active Pending
- 2022-10-19 EP EP25217993.2A patent/EP4717689A2/en active Pending
- 2022-10-19 WO PCT/CN2022/126169 patent/WO2023066296A1/en not_active Ceased
- 2022-10-19 FI FIEP22882901.6T patent/FI4399207T3/fi active
-
2024
- 2024-04-16 CO CONC2024/0004745A patent/CO2024004745A2/es unknown
- 2024-04-19 CL CL2024001231A patent/CL2024001231A1/es unknown
-
2025
- 2025-10-17 JP JP2025175882A patent/JP2026027273A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4138886B2 (ja) | ２−アミノ−４−（４−フルオルベンジルアミノ）−１−エトキシカルボニル−アミノベンゼンの新規変態ならびにその製造法 | |
| JP2024539212A5 (https=) | ||
| JP2009137975A5 (https=) | ||
| JP7300473B2 (ja) | 多形体及びキナゾリニル誘導体の調製プロセス | |
| WO1992004365A1 (en) | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions | |
| JP2003522175A (ja) | リネゾリド結晶形態ｉｉ | |
| JP2024095561A5 (https=) | ||
| WO2021236709A1 (en) | Solid state forms of tapinarof | |
| CN112469717B (zh) | 用于纯化艾沙康唑鎓硫酸盐的方法 | |
| CN101778836A (zh) | 在1,2-取代的3,4-二氧-1-环丁烯化合物中控制的晶体大小的方法 | |
| KR102657147B1 (ko) | 빌라스틴의 결정형 및 그의 제조 방법 | |
| WO2011051384A1 (en) | Process for making crystalline form a of linezolid | |
| KR20120096200A (ko) | 결정형 도세탁셀 및 이의 제조방법 | |
| JP2018505206A (ja) | アビラテロンプロピオネートの結晶形及びその製造方法 | |
| CN102070625A (zh) | 一种伊潘立酮的结晶方法 | |
| JP2025016547A (ja) | ２－［（４ｓ）－８－フルオロ－２－［４－（３－メトキシフェニル）ピペラジン－１－イル］－３－［２－メトキシ－５－（トリフルオロメチル）フェニル］－４ｈ－キナゾリン－４－イル］酢酸ナトリウム三水和物の結晶形を製造する方法 | |
| CN103772413B (zh) | 一种利福平ⅱ晶型的制备方法 | |
| CN103819487B (zh) | 一种利福平晶体及其制备方法 | |
| CN107311993A (zh) | 一种卡格列净的晶型ii及其制备方法 | |
| JP2022524741A5 (https=) | ||
| JP2021512893A5 (https=) | ||
| RU2024113526A (ru) | Кристаллические формы производных хиназолина, их получение, композиции и применение | |
| CN110615768A (zh) | 一种GnRHR药物的A晶型及其制备方法 | |
| WO2025201465A1 (zh) | 一种新的马来酸阿伐曲泊帕三水合物及其制备方法 | |
| CN120943775A (zh) | 一种依托考昔晶型iv的制备方法 |